Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events patient preferences considered first time fda decision approve first kind obesity
… projects have included: Benefit-risk preference studies Decision-analytic models (cost effectiveness, budget impact) … studies Outcomes research strategy development Patient-reported outcomes (PRO) studies (including instrument …
… but an increased mortality has been observed. The FDA, therefore, issued a black box warning for this …
… health. Recent projects have included: Database studies Decision-analytic models (cost effectiveness, budget impact) … quality-of-life analyses Literature reviews Measurement of patient preferences for treatment options Meta-analysis studies …
… but an increased mortality has been observed. The FDA, therefore, issued a black box warning for this …
Pharmacoepidemiology and Risk Management Regulatory Real-World Evidence Research Let us help you ensure the safety of your patients by examining and understanding disease indicators and using real-world evidence to support your development and …
… effects on efficacy, safety, and quality of life in the patient population and in subgroups of interest. In the … short treatment durations, combined they contained patient data spanning nearly 10 years. OUR APPROACH To assess long-term treatment effect, we first had to address database structure differences and …
… on drug development from preclinical through postmarketing Decision-analytic models (cost effectiveness, budget impact, … utilization studies Literature reviews Payer research Patient-reported outcomes (PRO) studies (including instrument … evaluations of PRO instruments Qualitative physician and patient research Reimbursement and value communication …
… confounding (baseline and after baseline) and proper time zero specification. We have experts who specialize in … emulation framework when exposures are sustained over time and thus require more involved methods than usual. To …
Webinar: Economic Modelling Challenges in Rare Diseases Share on: Wednesday, February 27, 2019 Watch the recording When seeking approval for rare disease products, demonstrating value for therapies can be a challenge. The limited amount of data available …
… using cross-sectional and longitudinal data sources Decision-analytic models (cost effectiveness, budget impact) … research strategy development Physician and payer research Patient-reported outcomes instrument development and …